Autism and ADHD: diagnosis and demand in neurodevelopmental care. Emanuel Miller International Online Conference
‘Autism and ADHD: diagnosis and demand in neurodevelopmental care’, The 2026 Emanuel Miller International Online Conference will explore current debates around autism and ADHD, focusing on how scientific evidence, diagnostic practices, and rising demand for assessment intersect within contemporary neurodevelopmental care. Bringing together leading experts, the programme will examine how changes in diagnostic frameworks, service pressures, and social contexts shape who receives a diagnosis, when, and with what implications for young people, families, and services. The conference aims to provide a reflective, evidence-informed space to critically engage with questions of diagnosis, demand, and care across different clinical and service contexts.
Confirmed speakers; Professor Sam Cortese, Professor Jonathan Green, Professor Will Mandy, Professor Petrus de Vries, Professor Stephen Hinshaw, and Professor Simonoff.
Booking
Sign up at this link or on the Book Now button at the top of the screen, and complete the form that follows. You’ll then receive an email confirmation and a link to the webinar, plus we’ll send you a calendar reminder nearer the time. Delegates will have exclusive access to recordings for 90 days after the event, together with slides. Plus you will get a personalised CPD/CME certificate via email.
- ACAMH Members MUST login to book onto the webinar in order to access this webinar and get a CPD/CME certificate
- Non-members this is a great time to join ACAMH, take a look at what we have to offer, and make the saving on these sessions
EARLY BIRD £99 (until 16/03/26, then £149) for ACAMH Members (Print, Online, Concession) Join now and save
EARLY BIRD £139 (until 16/03/26, then £199) ACAMH Learn Account holders
EARLY BIRD £139 (until 16/03/26, then £199) Non Members
£15 ACAMH Undergraduate/Postgraduate Members
FREE LMIC Members
Don’t forget as a charity any surplus made is reinvested back as we work to our vision of ‘Sharing best evidence, improving practice’, and our mission to ‘Improve the mental health and wellbeing of young people aged 0-25’.
About the speakers
Professor Samuele Cortese, MD, PhD is currently a National Institute for Health and Care Research (NIHR) Research Professor; Professor of Child and Adolescent Psychiatry at the University of Southampton; and Honorary Consultant for the Hampshire and Isle of Wight Healthcare National Health Service (NHS) Foundation Trust, United Kingdom. Prof. Cortese’s main research interests focus on neurodevelopmental disorders. He has published more than 450 peer-reviewed papers and has secured more than £23 million in funding as a principal or co-applicant. Since 2022, he has been included in the top 1% of scientists in the field of psychiatry and psychology (Clarivate- Web of Science) and has been ranked #1 worldwide for expertise in Attention-Deficit/Hyperactivity Disorder (ADHD) and neurodevelopmental disorders (Expertscape). Prof. Cortese sat on the Attention-Deficit/Hyperactivity Disorder NHS Taskforce and has been a member of the National Institute for Health and Care Excellence (NICE) committee on Digital Technologies for Assessing Attention-Deficit/Hyperactivity Disorder.
Jonathan Green is Professor of Child and Adolescent Psychiatry at University of Manchester and Hon Consultant Child and Adolescent Psychiatrist at the Royal Manchester Children’s Hospital. He studied medicine at Cambridge, Paediatrics in London and Psychiatry in Oxford before establishing clinical and research groups in Manchester, UK. He has focused clinically and in research on early social and relational development in children generally, and on autistic development in particular. His group has led development and testing of early parent-mediated interventions for autistic development for both pre-school diagnosed children (PACT) and in the pre-diagnostic stage (iBASIS); and built on this evidence to advocate an early developmental pathway approach to autistic care that is now being applied in UK and internationally. In the last few years, he has undertaken increasing participatory work with the autistic community, including discussion on neurodiversity and the ethics of intervention, explorations of autistic phenomenology and full co-design of a new anxiety intervention for young autistic children. Jonathan sat on the most recent UK NICE development group for autism. He is a Senior Investigator in NIHR, Fellow of the UK Academy of Medical Sciences, and UK Global Senior Leader for autism for the International Society of Autism Research (INSAR).
Professor Will Mandy is a clinical psychologist and professor at University College London (UCL), where he is joint director of the UCL clinical psychology training course, which is the largest of its kind in Europe. His work aims to improve the recognition of autism, and to develop new interventions to help autistic people. He has a particular research interest in improving the identification and care of females on the autism spectrum, who are currently at high risk of going unnoticed and unhelped by clinical and educational services. He also studies sub-diagnostic autistic traits in non-clinical populations, and the role these can play in the development of a range of common childhood, adolescent and adult mental health problems. With colleagues at Great Ormond Street Hospital’s National Centre for High-Functioning Autism he has developed and trialled interventions to help children with autism transition from primary to secondary school, and to teach children about their autism diagnosis, with an emphasis on fostering their sense of self-worth and pride.
Professor Emily Simonoff is a Professor of Child and Adolescent Psychiatry and Head of the Department of Child and Adolescent Psychiatry at King’s College London. She also serves as the Academic Lead for the CAMHS Clinical Academic Group within King’s Health Partners. As a Senior Investigator with the National Institute of Health and Care Research (NIHR), her work bridges academic research and clinical practice to advance the understanding and treatment of mental health challenges in children and adolescents. Emily is also a Theme Lead for Child Mental and Neurodevelopmental Disorders in the Maudsley Biomedical Research Centre. Simonoff’s interests include Autism, ADHD, Intellectual Disability; Antisocial behaviour; Genetics and Epidemiology. Her other roles include Chair of the European ADHD Guidelines Group, member of the Steering Committee for Eunethydis (the European Hyperkinetic Disorder Network), Chair of the Mental Health Study Group for Autistica and past Senior Clinical Advisor to the National Institute of Health and Clinical Excellence (NICE).
Professor Petrus de Vries is the Sue Struengmann Professor of Child & Adolescent Psychiatry, and Director of the Centre for Autism Research in Africa at the University of Cape Town. He trained in Medicine at Stellenbosch University in South Africa before moving to the UK where he completed his clinical training in Psychiatry and Child & Adolescent Psychiatry, and a PhD in Developmental Neuroscience at the University of Cambridge. He has a clinical research interest in assessment and intervention for infants, young children and adolescents with complex neurodevelopmental and mental health needs. Since his return to South Africa he has focused on global child & adolescent mental health and on implementation science in low- and middle-income settings. Apart from his interest in autism, he has a longstanding clinical research programme in Tuberous Sclerosis Complex (TSC) and its associated neuropsychiatric disorders (TAND). He was the chairman of the International Neuropsychiatry Panel that coined the term ‘TAND’ and was lead developer and author of the TAND Checklist. Apart from his work on TAND, he was also closely involved in the phase II and III clinical trials of mTOR inhibitors for brain tumours (SEGA), renal tumours (AML) and treatment-resistant epilepsy in TSC. These studies have led to FDA and EMA approval for mTOR inhibitors as molecularly-targeted treatments in TSC. He also co-led two studies of mTOR inhibitors for TAND.
Professor Stephen P. Hinshaw is Distinguished Professor of Psychology at UC Berkeley and Professor of Psychiatry and Behavioral Sciences at UC San Francisco. He focuses on neurodevelopment (especially ADHD) through longitudinal studies, clinical trials, and a focus on developmental pathways in girls and women. His other core area is related to stigma reduction, including both narrative accounts and research studies. He received his A.B. from Harvard (summa cum laude) and his Ph.D. from UCLA. He has authored over 439 articles/chapters plus 11 books. His memoir, Another Kind of Madness, detailing the serious mental illness in his family and the doctor-ordered silence about the whole topic, was awarded Best Book in Memoir/Autobiography from the American BookFest in 2018. Hinshaw co-directs the UCSF-UC Berkeley Schwab Dyslexia and Cognitive Diversity Center.
Among his national and international awards, he has received accolades in clinical psychology (Distinguished Scientist Award, Society for a Science of Clinical Psychology), child development (Distinguished Scientific Contributions, Society for Research in Child Development), applied psychology (James Cattell Award, Association for Psychological Science), basic research in psychology (Distinguished Scientific Contributions, American Psychological Association), child and adolescent psychiatry (Ruane Prize, Brain & Behavior Research Foundation), international mental health (Sarnat International Prize, National Academy of Medicine), international research on ADHD (Eunethydis). He is the only individual to have received such awards in all seven of these fields. He is also an award-winning teacher and mentor. He was inducted into the American Academy of Arts and Sciences in 2021. Extensive media coverage includes the New York Times, Washington Post, Today Show, CBS Evening News, PBS, and more.
- Apr 16 2026
- Expired!
- 9:30 am - 3:30 pm
